Titanium and refractory metal powder producer Amaero (AMRO.US) has submitted an IPO application, aiming to raise $50 million.
The manufacturer of titanium and refractory metal powders for defense and aerospace 3D printing, Amaero (AMRO.US), recently filed an IPO prospectus with the U.S. Securities and Exchange Commission, planning to raise up to $50 million through the offering.
The defense and aerospace 3D printing manufacturer Amaero (AMRO.US) has recently submitted a prospectus to the U.S. Securities and Exchange Commission (SEC) to raise up to $50 million through an initial public offering (IPO) and plans to list on the Nasdaq Stock Exchange.
Amaero specializes in the production of refractory metal and titanium alloy spherical metal powders for additive manufacturing, as well as providing large near-net-shape components made using powder metallurgy hot isostatic pressing processes. Its products include powdered materials such as niobium, tungsten, tantalum, molybdenum, rhenium, and titanium alloys, specifically designed for the 3D printing of critical components in fields such as hypersonic weapon systems, satellite propulsion, strategic missiles, aerospace, and medical applications.
The company is currently listed on the Australian Securities Exchange under the stock code "3DA".
Amaero is headquartered in McDonald, Tennessee, USA, and was founded in 2013. For the twelve months ending June 30, 2026, the company achieved revenue of approximately $12 million. This planned Nasdaq listing anticipates the code "AMRO". The application was submitted confidentially on July 10, 2026. The offering is being managed by Stifel and Baird as co-bookrunners, although the company has not disclosed specific pricing terms.
Related Articles

Long Jian Road & Bridge (600853.SH) has been approved to register 500 million yuan in medium-term notes.
.png)
FORTUNE SUN (00352) has delayed the release of its interim results for 2026.

JP Morgan: Maintains "Overweight" Rating on HANSOH PHARMA (03692), Target Price Raised to 50 HKD
Long Jian Road & Bridge (600853.SH) has been approved to register 500 million yuan in medium-term notes.

FORTUNE SUN (00352) has delayed the release of its interim results for 2026.
.png)
JP Morgan: Maintains "Overweight" Rating on HANSOH PHARMA (03692), Target Price Raised to 50 HKD

RECOMMEND





